CRIS Current Research Information System

VITALI, BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.385
NA - Nord America 10.118
AS - Asia 8.623
AF - Africa 831
SA - Sud America 529
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 10
Totale 36.521
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.992
IT - Italia 9.310
CN - Cina 2.744
SG - Singapore 2.594
GB - Regno Unito 2.046
DE - Germania 1.158
VN - Vietnam 1.128
SE - Svezia 906
HK - Hong Kong 646
IN - India 538
FR - Francia 486
NL - Olanda 457
RU - Federazione Russa 438
BR - Brasile 376
UA - Ucraina 370
IE - Irlanda 291
KR - Corea 232
CI - Costa d'Avorio 227
ZA - Sudafrica 179
JP - Giappone 146
TG - Togo 144
PK - Pakistan 142
FI - Finlandia 120
EE - Estonia 113
CH - Svizzera 110
ID - Indonesia 100
NG - Nigeria 93
SC - Seychelles 92
CA - Canada 75
BE - Belgio 74
AR - Argentina 72
BG - Bulgaria 69
JO - Giordania 64
IR - Iran 60
PL - Polonia 60
ES - Italia 59
GR - Grecia 51
TR - Turchia 46
HR - Croazia 43
EG - Egitto 39
AT - Austria 32
MX - Messico 29
RO - Romania 29
DZ - Algeria 28
CL - Cile 23
PT - Portogallo 21
DK - Danimarca 20
MY - Malesia 20
AU - Australia 19
PH - Filippine 19
BD - Bangladesh 18
SM - San Marino 18
TW - Taiwan 18
CZ - Repubblica Ceca 17
IQ - Iraq 17
UZ - Uzbekistan 17
LB - Libano 14
RS - Serbia 14
EC - Ecuador 12
NO - Norvegia 12
TH - Thailandia 12
CO - Colombia 11
SK - Slovacchia (Repubblica Slovacca) 11
LT - Lituania 10
PE - Perù 10
SA - Arabia Saudita 9
UY - Uruguay 9
IL - Israele 8
AL - Albania 7
DO - Repubblica Dominicana 7
HU - Ungheria 7
AE - Emirati Arabi Uniti 6
NZ - Nuova Zelanda 6
VE - Venezuela 6
XK - ???statistics.table.value.countryCode.XK??? 6
MA - Marocco 5
PY - Paraguay 5
BO - Bolivia 4
CM - Camerun 4
KZ - Kazakistan 4
LU - Lussemburgo 4
MT - Malta 4
SI - Slovenia 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BZ - Belize 3
LK - Sri Lanka 3
PA - Panama 3
SN - Senegal 3
AM - Armenia 2
BY - Bielorussia 2
CY - Cipro 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GH - Ghana 2
IS - Islanda 2
KE - Kenya 2
KH - Cambogia 2
ME - Montenegro 2
Totale 36.486
Salva come PNG Salva come JPEG
Città #
Southend 1.762
Singapore 1.629
Ashburn 1.182
Bologna 817
Chandler 817
Fairfield 759
Milan 688
Hong Kong 631
Rome 618
Hefei 543
Santa Clara 488
Wilmington 423
Ann Arbor 384
Seattle 380
Princeton 379
Woodbridge 362
Beijing 348
Houston 338
Cambridge 286
Dublin 280
Boardman 270
Dallas 250
Frankfurt am Main 248
Naples 234
Abidjan 227
Seoul 221
Dong Ket 218
Jacksonville 192
Padova 192
Turin 190
Ho Chi Minh City 189
Los Angeles 181
Florence 177
Nanjing 176
Westminster 156
Lomé 144
Berlin 139
Hanoi 136
New York 120
Tokyo 119
Jinan 99
Buffalo 96
Modena 93
Redmond 92
Bari 87
Catania 87
Medford 85
Saint Petersburg 85
Cesena 83
Helsinki 79
Palermo 74
Redondo Beach 73
Abeokuta 72
Shenyang 72
Shanghai 68
Bengaluru 67
Sofia 67
San Diego 66
Dearborn 65
Lahore 65
Nanchang 65
Amman 62
Munich 61
Hebei 56
Falls Church 54
Tianjin 54
Verona 54
Bern 52
Changsha 52
Jakarta 52
Guangzhou 51
Brussels 47
Redwood City 47
São Paulo 47
Gujranwala 46
Parma 46
Mülheim 45
Perugia 40
Genoa 39
Zhengzhou 39
Forlì 38
Pescara 38
Amsterdam 37
Cagliari 37
Chicago 37
Des Moines 34
London 34
Hyderabad 32
Phoenix 32
Tukwila 32
San Jose 31
Brescia 29
Ningbo 29
Ancona 28
Hangzhou 28
Jiaxing 28
Reggio Emilia 28
Yubileyny 28
Falkenstein 25
Monza 25
Totale 20.107
Salva come PNG Salva come JPEG
Nome #
VSL#3 in gravidanza: impatto sul microbiota e sulla risposta immune vaginale 6.169
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 629
STUDIO IN VITRO DELL’ATTIVITA’ ANTI-FUNGINA DI UN ESTRATTO DI SPIRULINA PLATENSIS: UN NUOVO APPROCCIO PER IL TRATTAMENTO DELLE CANDIDOSI MUCO-CUTANEE? 604
In vitro anti-Candida activity of a Spirulina platensis extract: a new approach for the treatment of fungal infections? 574
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 423
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 296
MICROBIOTA VAGINALE IN CORSO DI INFEZIONI DEL TRATTO GENITALE 295
Inserti vaginali mucoadesivi costituiti da complessi di chitosano e alginato per il rilascio locale di clorexidina digluconato 278
Identification of vaginal bacteria 267
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study 258
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 253
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 243
Isolation of vaginal lactobacilli and characterization of anti-candida activity 240
In vitro activity of Spirulina platensis water extract against different Candida species isolated from vulvo-vaginal candidiasis cases. 225
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion 220
Genotypic and phenotypic characterization of Lactobacillus strains with antipathogenic activities 218
An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota 215
Characterization and Heterologous Expression of the Oxalyl Coenzyme A Decarboxylase Gene from Bifidobacterium lactis 208
Impact of fermented soy beverages containing selected vaginal probiotics on the in vitro fecal microbiota of post-menopausal women 204
Identification method based on PCR combined with automated ribotyping for tracking probiotic Lactobacillus strains colonizing the human gut and vagina 202
Evaluation of the rrn operon copy number in Bifidobacterium using real-time PCR 202
Drug-in-cyclodextrin-in-polymeric nanoparticles: A promising strategy for rifampicin administration 200
Spanish Broom (Spartium junceum L.) fibers impregnated with vancomycin-loaded chitosan nanoparticles as new antibacterial wound dressing: Preparation, characterization and antibacterial activity 199
Azithromycin-loaded liposomes and niosomes for the treatment of skin infections: influence of excipients and preparative methods on the functional properties 198
Diversity of vaginal microbiome and metabolome during genital infections 197
Determination of antibacterial and technological properties of vaginal lactobacilli for their potential application in dairy products 195
Development of azithromycin-loaded microemulsions for the treatment of skin infections 189
Development of a Fermented Milk Designed for Women's Well-Being Containing an Exopolysaccharides-Producing Starter Culture and a Functional Vaginal Strain 187
Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models 186
VAGINAL MICROBIOME FOR THE PRESERVATION OF WOMEN’S HEALTH USING FOOD STRATEGY 186
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 183
Investigation on the effects of antimicrobial imidazo[2,1-b]thiazole derivatives on the genitourinary microflora 183
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali 182
High-dose probiotics for the treatment of active pouchitis 181
Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants 181
Development and characterization of fermented soy beverages containing encapsulated or non-encapsulated vaginal probiotics 180
Rifaximin modulates the colonic microbiota of patients with Crohn’s disease: an in vitro approach using a continuous culture colonic model system 180
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 180
Chitosan/alginate complexes for vaginal delivery of chlorhexidine digluconate 179
Computer vision approach for the determination of microbial concentration and growth kinetics using a low cost sensor system 178
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 177
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 175
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 175
Novel probiotic candidates for humans isolated from raw fruits and vegetables 172
Anti-bacterial activity of vaginal lactobacilli against Chlamydia trachomatis 171
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 170
Novel mixed vesicles containing lactobacilli biosurfactants for vaginal delivery of econazole nitrate 170
Bacterial concentration detection using a portable embedded sensor system for environmental monitoring 170
Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis 168
Antioxidant and Functional Features of Pre-Fermented Ingredients Obtained by the Fermentation of Milling By-Products 167
Real-time PCR quantification of bacterial adhesion to Caco-2 cells: Competition between bifidobacteria and enteropathogens 167
Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride 166
OralArray: a new phylogenetic DNA-microarray to characterize the oral microbiota 165
New hybrids with 2-aminobenzothiazole and azelayl scaffolds: Synthesis, molecular docking and biological evaluation 165
Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by 1H Nuclear Magnetic Resonance spectroscopy 163
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 162
Azithromycin-loaded vesicles for the treatment of skin infections: a comparative study of different formulations 159
Development and Characterization of Azithromycin-Loaded Microemulsions: A Promising Tool for the Treatment of Bacterial Skin Infections 158
null 156
In-vitro effect of vaginal lactobacilli against group B Streptococcus 156
A proteomic view of Bifidobacterium infantis generated by multi-dimensional chromatography coupled with tandem mass spectrometry 156
Insight into phenotypic and genotypic differences between vaginal Lactobacillus crispatus BC5 and Lactobacillus gasseri BC12 to unravel nutritional and stress factors influencing their metabolic activity 156
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system-authors' response 155
Protocol for the Use of PCR-Denaturing Gradient Gel Electrophoresis and Quantitative PCR to Determine Vaginal Microflora Constitution and Pathogens in Bacterial Vaginosis 153
Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion 151
Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis 151
Vaginal Lactobacillus Impair Candida Dimorphic Switching and Biofilm Formation 150
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 149
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 148
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 148
Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real time PCR study 147
High taxonomic level fingerprint of the human intestinal microbiota by Ligase Detection Reaction - Universal Array approach. 146
Studio in vitro dell’attività antimicrobica di lattobacilli vaginali nei confronti di Chlamydia trachomatis. 146
Polymer–lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate 145
Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis. 145
Electrical Impedance Spectroscopy (EIS) characterization of saline solutions with a low-cost portable measurement system 144
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections 143
Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections 143
Limosilactobacillus vaginalis Exerts Bifidogenic Effects: A Novel Postbiotic Strategy for Infant Prebiotic Supplementation 142
Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis 140
Bifidobacterium lactis Enolase, surface localization and mechanism of interaction with human Plasminogen 139
Vaginal lactobacillus inhibits HIV-1 replication in human tissues ex vivo 139
Metabolic profiling of Candida clinical isolates of different species and infection sources 138
Chitosan nanoparticles combined with sulphobutylether-β-cyclodextrin for rifampicin administration 137
Correlation of Atopobium vaginae amount with bacterial vaginosis markers 137
Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota 136
Isolation and characterization of biosurfactants produced by Lactobacillus gasseri of vaginal origin 136
Evaluation of the fate of Lactobacillus crispatus BC4, carried in Squacquerone cheese, throughout the simulator of the human intestinal microbial ecosystem (SHIME) 136
Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing 135
Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets 135
Human Breast Milk: A Source of Potential Probiotic Candidates 134
A portable sensor system for bacterial concentration monitoring in metalworking fluids 131
Mucoadhesive Buccal Films for Local Delivery of Lactobacillus brevis 131
Method for diagnosis vaginal infections 130
Lactobacillus crispatus interferes with Chlamydia trachomatis infectivity through modulation of integrin exposure in cervical cells 130
Lactobacilli cell-free supernatants: Potential green and natural enhancers for nose-to-brain delivery of small hydrophilic molecules 129
The effects of probiotic bacteria on spontaneous contraction of isolated guinea-pig intestine 128
null 128
Lactobacillus crispatus to produce a functional cheese as dietary strategy to improve woman wellbeing 128
Probiotic and metabolic characterization of vaginal lactobacilli for a potential use in functional foods 128
Totale 24.722
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.295
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.113 0 0 0 0 0 161 111 191 351 204 219 876
2021/20224.084 336 194 237 241 434 253 201 307 200 312 769 600
2022/20235.233 492 619 271 542 391 417 289 334 801 284 446 347
2023/20243.488 250 348 273 319 314 526 228 202 204 337 237 250
2024/20258.160 446 942 817 661 1.014 534 851 470 338 495 466 1.126
2025/20267.060 1.248 1.478 1.331 1.112 1.531 360 0 0 0 0 0 0
Totale 37.241